FMBA Russia

• 2024 Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model.

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format